(-)cis-5,7-dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one,
alvocidib,
flavopiridol,
HMR 1275,
L 868275,
L-868275,
L86-8275,
Flavopiridol,
Alvocidib,
146426-40-6,
Flavopiridol (Alvocidib),
Flavopiridol hydrochloride,
FLAVO,
L 868275,
L-868275,
HMR-1275,
UNII-45AD6X575G,
L86-8275,
HMR 1275,
HMR 1274,
L 86-8275,
CHEMBL428690,
45AD6X575G,
2-(2-chlorophenyl)-5,7-dihydroxy-8-((3S,4R)-3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-one,
2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]-4H-chromen-4-one,
(-)cis-5,7-Dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one,
2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE,
131740-09-5,
MDL-107826A,
HL 275,
C21H20ClNO5,
2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-4-piperidyl]chromen-4-one,
L868275,
Flavoperidol,
Alvocidib [INN],
4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-5,7-dihydroxy-8-((3R,4S)-3-hydroxy-1-methyl-4-piperidinyl)-, rel-(-)-,
4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methyl-4-piperidinyl)-, cis-(-)-,
Alvocidib [USAN:INN],
alvocidibum,
CCRIS 9399,
Alvocidib freebase,
L-86-8275,
2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one,
AC1NRALK,
NSC649890,
Tube001,
1c8k,
1e1y,
Alvocidib (USAN/INN),
SCHEMBL3652,
BDBM5655,
GTPL5680,
NSC 649890 HCl,
CHEBI:47344,
EX-A1901,
Flavopiridol,Alvocidib, HMR-1275,
HMR-1274,
KS-00000XH5,
AN-500,
MFCD20501884,
s1230,
ZINC21288966,
AKOS022182942,
AM84422,
DB03496,
(-)-cis-5,7-dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one,
4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-4-piperidinyl]-,
AJ-78086,
AN-16495,
BC220865,
HY-10005,
LS-173272,
FT-0601569,
A25160,
D09868,
104780-EP2289877A1,
104780-EP2292601A1,
104780-EP2292603A1,
104780-EP2298739A1,
104780-EP2298771A2,
J-008219,
BRD-K87909389-001-01-2,
HMR-1275, L868275, 146426-40-6,
2-(2-chlorophenyl)-5,7-dihydroxy-8-((3S,4R)-3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-one;Alvocidib,
4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-2,3-dihydro-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-4-piperidinyl]-,
5,7-Dihydroxy-2-(2-chlorophenyl)-8-(1-methyl-3beta-hydroxypiperidin-4beta-yl)-4H-1-benzopyran-4-one,
Alvocidib|||L-868275|||HMR-1275|||2-(2-Chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one,
Alvocidib [USAN],
Tetrabenzyl-voglibose,
Alvocidib hydrochloride,
C21H20ClNO5.ClH,
D0LF1U,
UNII-D48MS3A6N9,
Alvocidib [USAN:INN:BAN],
cc-206,
Alvocidib hydrochloride [USAN],
C21-H20-Cl-N-O5,
NSC-649890,
C21-H20-Cl-N-O5.Cl-H,
MDL 107826A,
NSC 107826A,
Alvocidib [USAN:INN] hydrochloride,
HL-275,
ACN-035778,
CID5287969,
CS-0018,
NSC 649890,
HMR-1275, Alvocidib, L868275, Flavopiridol,
C077990,
CPB,
2-(2-chlorophenyl)-5,7-dihydroxy-8-((3S,4R)-3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-one hydrochloride,
2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3s,4r)-3-hydroxy-1-methyl-4-piperidinyl]-4h-1-benzopyran-4-one,